1 Day
Source:
وكالة الأنباء القطرية
FDA approves first mRNA flu vaccine
The U.S. Food and Drug Administration (FDA) has approved the first flu vaccine based on mRNA technology, produced by Moderna. The vaccine is called "mFLUSIVA" and is authorized for use in adults aged 50 and older. It is expected to become available in the United States during the 2026-2027 respiratory virus season. This decision follows a previous rejection by the agency of the company's request for a review of the vaccine, but approval was granted after an encouraging meeting and several months of anticipation. This vaccine supports ongoing efforts to develop influenza vaccines using modern technology, despite the challenges the company faced regarding approval of the technology and securing federal funding for its use.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)